MTA1 and prostate carcinoma: To explore the clinical significance of the MTA1 and CTSB interrelationship in prostate cancer, we examined the expression of MTA1 and CTSB in a limited cohort of five prostate adenocarcinoma biopsies obtained previously (Dhar et al., 2017).